Dr Reddys Laboratories has informed that the Board of Directors of the Company, at their meeting held on May 9, 2025, has transacted and approved the following businesses: Approved the Audited Financial Results of the Company for the quarter and year ended March 31, 2025. In terms of the above, they are enclosing: 1. Audited Consolidated Financial Results of the Company for the quarter and year ended March 31, 2025, as per the International Financial Reporting Standards (IFRS) as issued by International Accounting Standards Board (IASB); Press Release on Financial Results of the Company for the above period; Audited Consolidated Financial Results of the Company for the quarter and year ended March 31, 2025, as per Indian Accounting Standards; Audited Standalone Financial Results of the Company for the quarter and year ended March 31, 2025, as per Indian Accounting Standards.
The above information is a part of company’s filings submitted to BSE.
